Patent classifications
A01N43/44
PESTICIDALLY ACTIVE CYCLIC AMINE COMPOUNDS
Compounds of formula (I) wherein the substituents are as defined in claim 1, and the agrochemically acceptable salts, stereoisomers, enantiomers, tautomers and N-oxides of those compounds, can be used as insecticides.
##STR00001##
PESTICIDALLY ACTIVE CYCLIC AMINE COMPOUNDS
Compounds of formula (I) wherein the substituents are as defined in claim 1, and the agrochemically acceptable salts, stereoisomers, enantiomers, tautomers and N-oxides of those compounds, can be used as insecticides.
##STR00001##
METHOD FOR PATHOGENS, MICROORGANISMS, AND PARASITES INACTIVATION
Described herein are methods for inactivation or reduction of pathogens, microorganisms or parasites in a sample, media, composition, utility, device, surface or organism by treatment with an alkylating compound of Structure I, followed by elimination or reduction of the residual compound of Structure I by treatment with a neutralizing agent, which eliminates or reduces the toxicity or other undesirable properties of the alkylating compound having Structure I. The neutralizing agent can be present in a treatment solution or be part of a solid-phase agent, and acts by eliminating the alkylating properties of the alkylating compound of Structure I.
METHOD FOR PATHOGENS, MICROORGANISMS, AND PARASITES INACTIVATION
Described herein are methods for inactivation or reduction of pathogens, microorganisms or parasites in a sample, media, composition, utility, device, surface or organism by treatment with an alkylating compound of Structure I, followed by elimination or reduction of the residual compound of Structure I by treatment with a neutralizing agent, which eliminates or reduces the toxicity or other undesirable properties of the alkylating compound having Structure I. The neutralizing agent can be present in a treatment solution or be part of a solid-phase agent, and acts by eliminating the alkylating properties of the alkylating compound of Structure I.
Use as rodenticides of compounds that inhibit blood coagulation
The invention relates to a use, a method and a poison in which a thrombin inhibitor, a thrombin receptor antagonist, a factor Xa inhibitor, a PAI (plasminogen activator inhibitor), a P2Y12 ADP receptor antagonist or a GPIIb/IIIa receptor antagonist are used as rodenticide.
Use as rodenticides of compounds that inhibit blood coagulation
The invention relates to a use, a method and a poison in which a thrombin inhibitor, a thrombin receptor antagonist, a factor Xa inhibitor, a PAI (plasminogen activator inhibitor), a P2Y12 ADP receptor antagonist or a GPIIb/IIIa receptor antagonist are used as rodenticide.
Use as rodenticides of compounds that inhibit blood coagulation
The invention relates to a use, a method and a poison in which a thrombin inhibitor, a thrombin receptor antagonist, a factor Xa inhibitor, a PAI (plasminogen activator inhibitor), a P2Y12 ADP receptor antagonist or a GPIIb/IIIa receptor antagonist are used as rodenticide.
USE OF STROBILURIN TYPE COMPOUNDS FOR COMBATING PHYTOPATHOGENIC FUNGI CONTAINING AN AMINO ACID SUBSTITUTION F129L IN THE MITOCHONDRIAL CYTOCHROME B PROTEIN CONFERRING RESISTANCE TO QO INHIBITORS II
- Andreas Koch ,
- Marcus Fehr ,
- Vanessa Tegge ,
- Chandan Dey ,
- Manojkumar Poonoth ,
- Sarang Kulkarni ,
- Ronan Le Vezouet ,
- Christian Harald Winter ,
- Georg Christoph Rudolf ,
- Rakesh Rath ,
- Smriti Khanna ,
- lan Robert Craig ,
- Wassilios Grammenos ,
- Thomas Grote ,
- Gerd Stammler ,
- Tobias Mentzel ,
- Egon Haden ,
- Joachim Rheinheimer
The present invention relates to the use of strobilurin type compounds of formula I and the N-oxides and the salts thereof for combating phytopathogenic fungi containing an amino acid substitution F129L in the mitochondrial cytochrome b protein (also referred to as F129L mutation in the mitochondrial cytochrome b gene) conferring resistance to Qo inhibitors, and to methods for combating such fungi. The invention also relates to novel compounds, processes for preparing these compounds, to compositions comprising at least one such compound, and to seeds coated with at least one such compound.
USE OF STROBILURIN TYPE COMPOUNDS FOR COMBATING PHYTOPATHOGENIC FUNGI CONTAINING AN AMINO ACID SUBSTITUTION F129L IN THE MITOCHONDRIAL CYTOCHROME B PROTEIN CONFERRING RESISTANCE TO QO INHIBITORS II
- Andreas Koch ,
- Marcus Fehr ,
- Vanessa Tegge ,
- Chandan Dey ,
- Manojkumar Poonoth ,
- Sarang Kulkarni ,
- Ronan Le Vezouet ,
- Christian Harald Winter ,
- Georg Christoph Rudolf ,
- Rakesh Rath ,
- Smriti Khanna ,
- lan Robert Craig ,
- Wassilios Grammenos ,
- Thomas Grote ,
- Gerd Stammler ,
- Tobias Mentzel ,
- Egon Haden ,
- Joachim Rheinheimer
The present invention relates to the use of strobilurin type compounds of formula I and the N-oxides and the salts thereof for combating phytopathogenic fungi containing an amino acid substitution F129L in the mitochondrial cytochrome b protein (also referred to as F129L mutation in the mitochondrial cytochrome b gene) conferring resistance to Qo inhibitors, and to methods for combating such fungi. The invention also relates to novel compounds, processes for preparing these compounds, to compositions comprising at least one such compound, and to seeds coated with at least one such compound.
USE OF STROBILURIN TYPE COMPOUNDS FOR COMBATING PHYTOPATHOGENIC FUNGI CONTAINING AN AMINO ACID SUBSTITUTION F129L IN THE MITOCHONDRIAL CYTOCHROME B PROTEIN CONFERRING RESISTANCE TO QO INHIBITORS III
- Andreas Koch ,
- Marcus Fehr ,
- Vanessa Tegge ,
- Chandan Dey ,
- Manojkumar Poonoth ,
- Sarang Kulkarni ,
- Ronan Le Vezouet ,
- Christian Harald Winter ,
- Georg Christoph Rudolf ,
- Rakesh Rath ,
- Smriti Khanna ,
- Ian Robert Craig ,
- Wassilios Grammenos ,
- Thomas Grote ,
- Gerd Stammler ,
- Tobias Mentzel ,
- Egon Haden ,
- Joachim Rheinheimer
The present invention relates to the use of strobilurin type compounds of formula I and the N-oxides and the salts thereof for combating phytopathogenic fungi containing an amino acid substitution F129L in the mitochondrial cytochrome b protein (also referred to as F129L mutation in the mitochondrial cytochrome b gene) conferring resistance to Qo inhibitors, and to methods for combating such fungi. The invention also relates to novel compounds, processes for preparing these compounds, to compositions comprising at least one such compound, and to seeds coated with at least one such compound.